文献速递肝胆胰外科胃肠外科

吲哚菁绿荧光成像在腹腔镜肝内胆管癌淋巴结清扫中的临床应用:一项先导研究(附视频)

Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: A pilot study (with video).
PubMed 文献 · Surgery · 2021-11-29

本先导研究回顾性分析了2018年10月至2021年1月接受腹腔镜左肝切除及淋巴结清扫的肝内胆管癌患者,评估吲哚菁绿荧光显像对淋巴引流的可视化效果及临床应用。结果显示,吲哚菁绿组收获淋巴结数量更多、病理确诊淋巴结比例更高,且术后并发症发生率与严重程度无差异。作者认为该技术可行、安全、有效,可用于识别区域淋巴引流模式并辅助界定淋巴结清扫范围。

要点

  • 吲哚菁绿组收获淋巴结中位数7.0枚,多于对照组的3.5枚(P < .001)。
  • 吲哚菁绿组病理确诊淋巴结比例75.0%,高于对照组的40%(P < .001)。
  • 两组术后30天并发症发生率与严重程度无差异(P > .05)。

核心结论

  • 吲哚菁绿荧光成像系统在肝内胆管癌淋巴结示踪中可行、安全且有效。
  • 该技术可用于识别区域淋巴引流模式,并帮助界定肝内胆管癌患者的淋巴结清扫范围。

研究设计与样本

  • 回顾性先导研究,纳入2018年10月至2021年1月期间接受腹腔镜左肝切除及淋巴结清扫的肝内胆管癌患者。
  • 38例左半肝肝内胆管癌患者中,20例接受吲哚菁绿示踪引导的腹腔镜根治性左肝切除术,其中12例手术成功(吲哚菁绿组)。
  • 同期18例患者接受传统腹腔镜切除术(对照组)。

主要发现

  • 吲哚菁绿组收获淋巴结数量中位数7.0枚(范围6.0-8.0),多于对照组的3.5枚(范围3.0-5.0),P < .001。
  • 吲哚菁绿组病理确诊淋巴结比例75.0%(66.7%-87.5%),高于对照组的40%(33.3%-50.0%),P < .001。
  • 两组术中因素相当,术后30天并发症发生率与严重程度无差异(P > .05)。
  • 吲哚菁绿组12例(12/12,100%)在8站和12站均观察到吲哚菁绿染色,9例(9/12,75%)在13站、10例(11/12,91.7%)在7站观察到染色。

临床怎么用

  • 作者认为吲哚菁绿荧光成像系统在肝内胆管癌淋巴结示踪中可行、安全且有效。
  • 作者认为该技术可用于识别区域淋巴引流模式,并帮助界定肝内胆管癌患者的淋巴结清扫范围。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrahepatic cholangiocarcinoma is a highly lethal malignancy characterized by lymph node metastasis. This study aimed to evaluate the efficacy of indocyanine green fluorescence for visualization of lymphatic drainage and to assess its clinical application during laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma. METHODS: All patients with intrahepatic cholangiocarcinoma who underwent laparoscopic left hepatectomy and lymph node dissection between October 2018 and January 2021 were reviewed. The patients were assigned to the indocyanine green group or non-intrahepatic cholangiocarcinoma group based on the staining technique used. RESULTS: Of 38 patients with left hemiliver intrahepatic cholangiocarcinoma, 20 underwent intrahepatic cholangiocarcinoma tracer-guided laparoscopic radical left hepatectomy; 12 procedures were successful (indocyanine green group). During the same period, 18 patients were treated with traditional laparoscopic resection (control group). Their intraoperative factors were comparable and there were no differences in the incidence or severity of their postoperative complications 30 days after surgery (P > .05). In the indocyanine green group, more lymph nodes were harvested (mean [range]: 7.0 [6.0-8.0] vs 3.5 [3.0-5.0], P < .001) and the proportion of confirmed pathologic lymph nodes was higher (75.0%, 66.7%-87.5% vs 40%, 33.3%-50.0%, P < .001). ICG staining was observed in all (12/12, 100%) patients in the intrahepatic cholangiocarcinoma group at stations 8 and 12, and 9 (9/12, 75%) and 10 (11/12, 91.7%) patients at Stations 13 and 7, respectively. CONCLUSION: The indocyanine green fluorescence imaging system is feasible, safe, and effective for tracing lymph nodes. It can be used to identify regional lymphatic drainage patterns and help define the scope of lymph node dissection in patients with intrahepatic cholangiocarcinoma.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Zhang Y, Zhu J, et al. Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: A pilot study (with video). Surgery. 2021. PMID: 34857382. doi:10.1016/j.surg.2021.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。